William Blair upgrades 10X Genomics stock rating on AI drug discovery role - Investing.com
<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxNZUlrZ1YzVFFCa0dpTDBqMG1HWGVaYndYOUc5VkxyeW5QM2Vab2JzSkltQkVXVXE3OEJwZFRSVEVZeXRBbDNfSWpmNzVaV0lCTndCZUF1QmFNakttejlWY1B5dDBILU50TF8xOFRLN1lJQk9ORmx5Wjk5R0dfWmpaTzBnVXdvdHk2ekotZUJrX29xRGw3NFZiNjNLRDFPRUFZcWJZZGo0V2tucmxUOXBMX1BjRWhCaGFuYzEwTHlHQUNlNXlrM2QxYktIT0JWeEE?oc=5" target="_blank">William Blair upgrades 10X Genomics stock rating on AI drug discovery role</a> <font color="#6f6f6f">Investing.com</font>
Could not retrieve the full article text.
Read on GNews AI drug discovery →Sign in to highlight and annotate this article
Conversation starters
Daily AI Digest
Get the top 5 AI stories delivered to your inbox every morning.
More about
stock
Big Tech firms are accelerating AI investments and integration, while regulators and companies focus on safety and responsible adoption.
<p>The AI landscape is experiencing unprecedented growth and transformation. This post delves into the key developments shaping the future of artificial intelligence, from massive industry investments to critical safety considerations and integration into core development processes.</p> <p><strong>Key Areas Explored:</strong></p> <ul> <li> <strong>Record-Breaking Investments:</strong> Major tech firms are committing billions to AI infrastructure, signaling a significant acceleration in the field.</li> <li> <strong>AI in Software Development:</strong> We examine how companies are leveraging AI for code generation and the implications for engineering workflows.</li> <li> <strong>Safety and Responsibility:</strong> The increasing focus on ethical AI development and protecting vulnerable users
《AI》SENSETIME-W(00020.HK) Displays Technical Pattern of Head Shoulders Top - AASTOCKS.com
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxPSU1vLVBxemtKUjg5SzV3THIteEs5OUdoU3NkalpMTHBuU01LSXMwNFdxVzBNZG9fVk9lYTMxYTIydVhvbzdrNEY2NUhDYUFXU0VKMzd5V2w4Wlc1eXJvdG5HeDh2dmE1czd0azU1RGh2cWhVMXB2SHl3c0dGRWFwU3U3d3NMTFV3MTBBcjZtMFFQWmNp?oc=5" target="_blank">《AI》SENSETIME-W(00020.HK) Displays Technical Pattern of Head Shoulders Top</a> <font color="#6f6f6f">AASTOCKS.com</font>
Meituan Stock (MPNGF) Drops Despite Emerging as Latest Chinese AI Champion - TipRanks
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxOaHZZNG5ydEp0Q01uWlVLUE8yWU1aZlRlb1pCdklXdEIwdUNyb2xhdllBVWY5MUM1eGFKOXk4cUEzZ2syNXQ0TzN4cjhKbTkyUWNMNjJNM3Z4bmhCUm5SRnpvZHZ4UEpkM0JKVHNKdDBfM1lHWmRMdDR1ZUpRazhFQjlvZEt2Ry1FMFliMkRmOFY4WTFZbk9zN3NmcWhwdnc0bGtyVg?oc=5" target="_blank">Meituan Stock (MPNGF) Drops Despite Emerging as Latest Chinese AI Champion</a> <font color="#6f6f6f">TipRanks</font>
Knowledge Map
Connected Articles — Knowledge Graph
This article is connected to other articles through shared AI topics and tags.
More in Market News
Trump says US could end war in Iran in 2 to 3 weeks
President Donald Trump said on Tuesday that the US could end its military campaign against Iran within two to three weeks. “We’ll be leaving very soon,” he told reporters in the White House’s Oval Office, adding that the exit could take place “within two weeks, maybe two weeks, maybe three”. The declaration was Trump’s clearest to date that he intends to soon end a month-long war that has reordered the Middle East, disrupted global energy markets and changed the trajectory of the...
Bill Gurley - The Gift and The Curse of Staying Private - [Invest Like the Best, EP.427]
My guest today is Bill Gurley. Bill was the general partner at Benchmark Capital. He joins me for his sixth time on Invest Like the Best with his most comprehensive market analysis yet, examining the realities reshaping venture capital. Bill tackles the uncomfortable math underlying today's venture returns, with companies staying private for far longer. He also walks through why no one—from GPs to LPs to founders—has proper incentives to mark assets accurately, creating a system-wide coordination problem. And, we dig into the investment implications of AI as a platform shift, ranging from evaluating AI revenue quality to international competitive dynamics. Bill offers crucial perspective on playing the game both as it exists today and as it may evolve. Please enjoy my conversation with Bil
Peter Lacaillade - Backing The Best Managers In Private Markets - [Invest Like the Best, EP.437]
My guest today is Peter Lacaillade. Peter is the Chief Investment Officer for Private Investments at SCS Financial and has built a notable private equity allocation platform within the wealth management industry. He shares his insights on how SCS's pooled vehicle structure has enabled them to compete with institutional giants, avoiding the adverse selection that plagues most wealth platforms. Peter shares his investment philosophy across lower middle market buyouts, emerging independent sponsors, and investing with what he believes to be category-defining managers. We discuss what separates high-quality private equity managers, the evolution of the industry toward AI-powered strategies, and private markets going mainstream. Please enjoy this conversation with Peter Lacaillade. For the full
Discussion
Sign in to join the discussion
No comments yet — be the first to share your thoughts!